DiamiR, LLC, a molecular diagnostics company, have announced the publication entitled "Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study" in Aging. Mild Cognitive Impairment is a condition characteristic of early stages of many neurodegenerative diseases, including Alzheimer's disease. The article can be accessed online here.
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment